Why the FDA paused monoclonal antibody treatments
Health experts are supporting limited use of two monoclonal antibody treatments after reports that they were ineffective against Omicron.
Health experts are supporting limited use of two monoclonal antibody treatments after reports that they were ineffective against Omicron.
Fewer and fewer locations are suitable for snow-loving sporting events.
Roads in the US are getting deadlier. A new strategy from the Department of Transportation will try to help.
Take control over your computer hard drive.
Injecting a quick workout to your day is simple, but with big benefits.
Fish bones and water lilies help pin down the exact timing of when the asteroid that wiped out the dinosaurs hit Earth.
To ensnare its meal, the Pacific footballfish puts on a dazzling light show by making and manipulating its own glow.
The company is making big boasts about producing new aircraft at a "superfactory" and then getting them airborne by 2026.
Researchers found membrane filters made with slimy, fermented microorganisms clogged less than their commercial counterparts.
Antarctic meteorite expeditions can be grueling, but scientists designed a new AI that could help locate hotspots.
It's OK to hate your pump—we all do.
Topics is Google’s new method of sharing user information with advertisers.
It's one small impact for the moon.
The eStream trailer motors along on electricity, so there's less pulling (and fuel) involved.
This major group of diverse bats are auditory innovators.
Some facts to consider before your next gua sha or sauna session.
The actor says the new species designation "made him smile."
The IRS will be requiring a video selfie, submitted through ID.me, for access to its website. Here's what to know.